These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 9789142

  • 1. Chemoprevention of colorectal cancer in inflammatory bowel disease? A potential role for folate.
    Mouzas IA, Papavassiliou E, Koutroubakis I.
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):421-5. PubMed ID: 9789142
    [Abstract] [Full Text] [Related]

  • 2. Chronic inflammatory bowel disease and cancer.
    Pohl C, Hombach A, Kruis W.
    Hepatogastroenterology; 2000 Aug; 47(31):57-70. PubMed ID: 10690586
    [Abstract] [Full Text] [Related]

  • 3. Review article: the effect of aminosalicylates and immunomodulation on cancer risk in inflammatory bowel disease.
    Stange EF.
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():64-7. PubMed ID: 16961748
    [Abstract] [Full Text] [Related]

  • 4. [Inflammatory bowel disease and colorectal cancer].
    Hagymási K, Tulassay Z.
    Orv Hetil; 2006 Oct 15; 147(41):1977-82. PubMed ID: 17120688
    [Abstract] [Full Text] [Related]

  • 5. Chemoprevention for colon cancer: new opportunities, fact or fiction?
    Terhaar Sive Droste JS, Tuynman JB, Van Dullemen HM, Mulder CJ.
    Scand J Gastroenterol Suppl; 2006 Oct 15; (243):158-64. PubMed ID: 16782636
    [Abstract] [Full Text] [Related]

  • 6. [Colorectal cancer in inflammatory bowel disease].
    Henriksen M, Moum B.
    Tidsskr Nor Laegeforen; 2007 Oct 18; 127(20):2696-9. PubMed ID: 17952155
    [Abstract] [Full Text] [Related]

  • 7. Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Triantafillidis JK, Nasioulas G, Kosmidis PA.
    Anticancer Res; 2009 Jul 18; 29(7):2727-37. PubMed ID: 19596953
    [Abstract] [Full Text] [Related]

  • 8. Colon cancer surveillance.
    Choi PM, Kim WH.
    Gastroenterol Clin North Am; 1995 Sep 18; 24(3):671-87. PubMed ID: 8809242
    [Abstract] [Full Text] [Related]

  • 9. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Sep 18; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 10. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease.
    Chan EP, Lichtenstein GR.
    Gastroenterol Clin North Am; 2006 Sep 18; 35(3):675-712. PubMed ID: 16952746
    [Abstract] [Full Text] [Related]

  • 11. Folic acid and sulfasalazine for colorectal carcinoma chemoprevention in patients with ulcerative colitis: the old and new evidence.
    Diculescu M, Ciocîrlan M, Ciocîrlan M, Piţigoi D, Becheanu G, Croitoru A, Spanache S.
    Rom J Gastroenterol; 2003 Dec 18; 12(4):283-6. PubMed ID: 14726972
    [Abstract] [Full Text] [Related]

  • 12. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from olmsted county, Minnesota.
    Jess T, Loftus EV, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC, Schleck CD, Tremaine WJ, Melton LJ, Munkholm P, Sandborn WJ.
    Gastroenterology; 2006 Apr 18; 130(4):1039-46. PubMed ID: 16618397
    [Abstract] [Full Text] [Related]

  • 13. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation.
    Itzkowitz SH, Yio X.
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul 18; 287(1):G7-17. PubMed ID: 15194558
    [Abstract] [Full Text] [Related]

  • 14. Reduction of colorectal cancer risk in patients with Crohn's disease.
    Lichtenstein GR.
    Rev Gastroenterol Disord; 2002 Jul 18; 2 Suppl 2():S16-24. PubMed ID: 12478240
    [Abstract] [Full Text] [Related]

  • 15. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S, Deleporte A, Moussata D, Nancey S, Flourié B, Reimund JM.
    Gastroenterol Clin Biol; 2009 Jun 18; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [Abstract] [Full Text] [Related]

  • 16. Review article: colorectal carcinoma and inflammatory bowel disease.
    Eaden J.
    Aliment Pharmacol Ther; 2004 Oct 18; 20 Suppl 4():24-30. PubMed ID: 15352890
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R.
    Mod Pathol; 2003 Apr 18; 16(4):347-58. PubMed ID: 12692200
    [Abstract] [Full Text] [Related]

  • 18. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
    Goldacre MJ, Wotton CJ, Yeates D, Seagroatt V, Jewell D.
    Eur J Gastroenterol Hepatol; 2008 Apr 18; 20(4):297-304. PubMed ID: 18334873
    [Abstract] [Full Text] [Related]

  • 19. [Tracing colorectal carcinoma in patients with inflammatory bowel disease].
    de Jong DJ, Nagengast FM.
    Ned Tijdschr Geneeskd; 2007 Dec 15; 151(50):2758-60. PubMed ID: 18232192
    [Abstract] [Full Text] [Related]

  • 20. Screening and surveillance of ulcerative colitis.
    Axon AT.
    Gastrointest Endosc Clin N Am; 1997 Jan 15; 7(1):129-45. PubMed ID: 8995118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.